Cowen Aaron

Director, 10% Owner · Benitec Biopharma Inc.

Every open-market stock purchase Cowen Aaron has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought
$13.9M
Open-market buys
8
Companies
1
Last buy
Dec 29, 2025

Where the buys stand today

  • BNTC
    Benitec Biopharma Inc.
    −1.6% vs price paid

    8 purchases totalling $13.9M at an average of $12.95 per share; the stock last traded at $12.75. See all insider buying in BNTC

    Avg price paid
    $12.95
    Latest price
    $12.75
    Market cap
    $436.0M

Cluster participation

Buys that landed within days of other insiders buying the same stock — the pattern this site exists to catch.

All reported buys

DateTickerSharesPriceValueFiling
Dec 29, 2025
BNTCcluster
11,587$13.44$155.7KSEC ↗
Dec 29, 2025
BNTCcluster
65,800$13.44$884.4KSEC ↗
Dec 26, 2025
BNTCcluster
14,320$13.10$187.6KSEC ↗
Dec 23, 2025
BNTCcluster
42,600$12.85$547.4KSEC ↗
Mar 26, 2025
BNTCcluster
106,200$13.00$1.4MSEC ↗
Mar 26, 2025
BNTCcluster
793,800$13.00$10.3MSEC ↗
Dec 24, 202417,730$11.25$199.5KSEC ↗
Dec 23, 202424,360$10.98$267.5KSEC ↗

Get alerted the next time Cowen Aaron — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

About this data

Figures are parsed from Cowen Aaron's Form 4 filings on SEC EDGAR (CIK 1869640) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.